100707-54-8

Basic information

• Product Name: Methyl 4-AMinocyclohexanecarboxylate Hydrochloride (cis- and trans- Mixture)
• Synonyms: Methyl 4-AMinocyclohexanecarboxylate Hydrochloride (cis- and trans- Mixture);4-Aminocyclohexanecarboxylic Acid Methyl Ester Hydrochloride;Methyl 4-aminocyclohexylcarboxylate hydrochloride;Methyl 4-Aminocyclohexanecarboxylate HCl
• CAS NO: 100707-54-8
• Molecular Formula: C₈H₁₅NO₂*ClH
• Molecular Weight: 193.67114
• Mol File: 100707-54-8.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• Water Solubility: Soluble in water
• CAS DataBase Reference: Methyl 4-AMinocyclohexanecarboxylate Hydrochloride (cis- and trans- Mixture)(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-AMinocyclohexanecarboxylate Hydrochloride (cis- and trans- Mixture)(100707-54-8)
• EPA Substance Registry System: Methyl 4-AMinocyclohexanecarboxylate Hydrochloride (cis- and trans- Mixture)(100707-54-8)

Safety Data

• Hazardous Substances Data: 100707-54-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 4-Aminocyclohexanecarboxylate Hydrochloride (cisand transMixture) is used as an intermediate in the synthesis of various drugs and chemical products. Its versatile nature allows it to be a key component in the development of new pharmaceuticals.
Used in Organic Compounds Synthesis:
Methyl 4-Aminocyclohexanecarboxylate Hydrochloride (cisand transMixture) is used as a building block in the synthesis of various organic compounds. Its unique structure and properties make it a valuable component in the creation of new chemical entities.

Upstream product

• 146307-51-9 methyl (1R,4R)-4-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate 
• 67-56-1 methanol 
• 1776-53-0 trans-4-aminocyclohexanecarboxylic acid 

Downstream Products

• 1361951-15-6 2-((1R,4R)-4-((3-(3-(trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol 
• 1319742-68-1 trans-2-chloro-N-[4-(6-chloro-3,3-difluoro-2-oxo-2,3-dihydro-indol-1-ylmethyl)-cyclohexyl]-5-trifluoromethyl-benzamide 
• 1207529-71-2 trifluoro-methanesulfonic acid trans-4-(2-chloro-5-trifluoromethyl-benzoylamino)-cyclohexylmethyl ester 
• 1319743-29-7 trans-2-chloro-N-[4-(5-chloro-2-oxo-2,3-dihydro-indol-1-ylmethyl)-cyclohexyl]-5-trifluoromethyl-benzamide 
• 1207529-70-1 toluene-4-sulfonic acid trans-4-(2-chloro-5-trifluoromethyl-benzoylamino)-cyclohexylmethyl ester 
• 1319742-65-8 trans-2-chloro-N-[4-(6-chloro-2-oxo-2,3-dihydro-indol-1-ylmethyl)-cyclohexyl]-5-trifluoromethyl-benzamide 
• 1319742-72-7 trans-2-chloro-N-{-4-((5'-fluoro-2'-oxospiro[cyclopropane-1,3'-indoline]-1'-yl)methyl)cyctohexyl}-5-(trifluoromethyl)benzamide 
• 1319742-71-6 trans-2-chloro-N-[4-(2-oxo-2,3-dihydro-pyrrolo[2,3-b]pyridin-1-ylmethyl)-cyclohexyl]-5-trifluoromethyl-benzamide 
• 1319742-69-2 trans-2-chloro-N-[4-(3,3-dimethyl-2-oxo-2,3-dihydro-pyrrolo[2,3-b]pyridin-1-ylmethyl)-cyclohexyl]-5-trifluoromethyl-benzamide 
• 1207530-03-7 trans-2-chloro-N-(4-hydroxymethyl-cyclohexyl)-5-trifluoromethyl-benzamide 
• 1319743-48-0 trans-methanesulfonic acid 4-(2-chloro-5-trifluoromethyl-benzoylamino)-cyclohexyl methyl ester 
• 1207529-63-2 trans-4-(2-chloro-5-trifluoromethyl-benzoylamino)-cyclohexane carboxylic acid methyl ester 
• 733784-92-4 methyl trans-4-(1-piperidyl)cyclohexanecarboxylate 
• 167756-97-0 5-tert-butyloxycarbonyl-2-[4-[(trans-4-methoxycarbonyl-cyclohexyl)-aminocarbonyl]-phenyl]-4,5,6,7-tetrahydro-thiazolo[5,4-c]pyridine 

Relevant articles and documents

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS

Compounds of Formula (I) and salts thereof in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases and certain infectious diseases.

NITROGENOUS FUSED BICYCLIC COMPOUND

A novel nitrogenous fused bicyclic compound represented by the following general formula [1] or a pharmacologically acceptable salt of the compound. They have excellent SK channel blocking activity and are useful as a medicine. [I] (In the formula, R 0 represents hydrogen, halogeno, etc.; R 1 represents a group represented by the formula (a) or (b); A represents a group represented by the formula (X) or (Y); D 1 , D 2 and D 3 each represents N or CH; R 2 represents halogeno or optionally halogenated lower alkyl, etc.; R 3 represents hydrogen or lower alkyl; and Q represents lower alkylene.)

FUSED FURAN COMPOUND

The present invention provides a condensed furan compound of the formula (I): wherein Ring X is benzene, pyridine, or the like; Y is an optionally substituted amino, an optionally substituted cycloalkyl, an optionally substituted aryl, an optionally substituted saturated heterocyclic group, an optionally substituted unsaturated heterocyclic group; A is a single bond, lower alkylene, lower alkenylidene, lower alkenylene or an oxygen atom; R3 is hydrogen or the like; and , R4 is hydrogen, or the like, or pharmaceutically acceptable salts thereof, which is useful as a medicament, particularly, as an activated blood coagulation factor X inhibitor.